Oral Bioavailability is the rate and extent to which an active drug substance is absorbed and becomes available to the general circulation. A computational model for the prediction of oral bioavailability is a vital initial step in the drug discovery. It is decisive for selecting the promising compounds for the next level optimizations and recognition for the clinical trials. In the present investigation we aimed to perform the oral bioavailability prediction by comparing three machine learning methods i.e. Support Vector Machine (SVM) based kernel learning, Artificial Neural Network (ANN) and Bayesian classification approach. The overall prediction efficiency of SVM based model for the test set was 96.85%, whereas according to the Bayesian classifier and ANN methods prediction efficiency was found to be 92.19% and 94.53% respectively. Thus the present results clearly suggested that the SVM based prediction of oral bioavailability of drugs is more efficient binary classification approach for the data under consideration.
INTRODUCTION
Bioavailability is the amount of drug that reaches to the blood in an unchanged form, to carry out its pharmacological and therapeutic effect. It confers the rate at which the drugs get absorbed and the total amount that reaches to the systemic circulation. Understanding the bioavailability of a concern drug is crucial as the drug has to undergo a number of complicated biochemical pathways before producing the desired therapeutic effect. Hence, high oral bioavailability is among the most important consideration during drug development process.
There exists a plethora of studies to predict oral bioavailability which indicates that it is incredibly rich area of research. Oral bioavailability is usually determined in the preclinical stage of drug development process. Therefore, there is a need of a robust and accurate computational model which can predict the oral bioavailability of compounds without carrying out experiments. Various attempts in estimating oral bioavailability are reported in literature belonging to different categories viz. statistical analysis on known oral bioavailable drugs [12, 17] , mechanistic models [20, 22] , QSAR/QSPR models [16, 10] , genetic programming [3, 9] , Artificial Neural Networks (ANN), machine learning classification etc [19, 13] .
Classification is a process of developing a function which describes and/or distinguishes data on the bases of attributes [13] . Classification is a two step process. First is the learning or training step. It involves development of classifier describing the predetermined set of classes using a training set. This is also called supervised learning as classifier learns from a dataset in which classes are defined for each data. Second step involves testing of the classifier developed, in which a new data independent of the training set is used to determine the accuracy of clas-
The oral-bioavailability dataset used in this study was obtained from seven different sources [21, 6, 25, 15, 4, 8, 11] . Each drug molecule was represented with their chemical formulae and their bioavailability values. Dataset for this study comprises of total 511 drugs which are chemically diverse. Further the dataset of 511 drug molecules are randomly split into training and test set using 3:1 principle. Training set consists of 384 drugs whereas the test set consists of 127 drugs.
Calculation of descriptor values
Initially total 29 descriptors (physicochemical properties) were collected from various sources. The two softwares used for the calculation of all descriptors were the commercial versions of DRAGON [18] and TSAR (Supplementary: Tables 1-2) .
In our models we used diverse data set in order to avoid any biasness in it. For this purpose values of descriptors were plotted against each other to examine the diversity among the descriptors (Fig. 1 ).
Selection of optimal descriptors
In order to minimize the dimension feature space (a possible outcome of large number of descriptors), we have selected Sequential Forward Feature Selection (SFFS) algorithm. This facilitates identifying and removing the irrelevant and redundant information as much as possible to improve the performance of machine learning algorithms.
SFFS algorithm starts with an empty set of features. In first iteration, algorithm considers all feature subsets with only one feature. Feature subset with higher accuracy is used as basis of next iteration. Iteratively, algorithm tentatively adds to the basis each feature which was not previously selected and retains the feature subset that results in the highest estimated performance. The search terminates after the accuracy of the current subset cannot be improved by adding any other feature [1] . SFFS is stated as: Given a feature set X = {xi|i = 1 . . . N }, find a subset Y M = {xi . . . x M}, with M < N , which optimizes an objective function J (Y ). SFFS algorithm can be seen in Appendix.
Thus by implementing the SFFS algorithm we identified 12 descriptors as optimal features and selected for generation of the prediction model. These descriptors include Molecular Mass (MA), Total Hydrogen Count (HC), Total Polar Surface Area (TPSA), Partition Coefficient (logP), Rotatable Bonds (RTB), Shape Flexibility Index (SFI), Molecular Volume, Molecular Refractivity [14] , Molecular Surface Area (MSA), Solubility index (logS) [23] , Count of Hydroxyl groups (HYG) [22] and Sum of E-states indices (SESI) [5] .
Implementation of classification approaches
In present study, the aim is to construct a classifier for a given drug dataset which can differentiate drugs into two classes on the basis of their physicochemical properties. Classification is performed in such a way that each drug in the training data corresponds to a particular class and is represented by a set of features. Before employing any classification approach, assignment of class labels to whole drug data set was required. The constructed classifier is applied on the independent drug data set in order to predict the class label for it. We have defined two classes for the dataset 'low orally bioavailable (LO, less than 30 percent)' and 'high orally bioavailable (HO, greater than or equal to 30 percent)' [6] . Class labels were defined as 0 and 1 for LO and HO respectively.
In order to select suitable classifier, it was crucial to find out whether the data is linear or non-linear. We plotted the two defined classes for each of 12 descriptors. The distributions of data points for both the classes were found to be diverse, (Fig. 2 ) so non-linear classifiers were selected. In this study Support Vector Machine (SVM), Artificial Neural Network (ANN) and Bayesian classifiers were implemented to classify the drugs into LO and HO.
Classification by Support Vector Machine
In the present study LibSVM package (version 2.81) [2] was used to implement SVM. The training dataset was used as input for SVM based classification and following steps were performed: a) Scaling of data: Descriptors values were scaled within a numeric range -1 and 1 [7] . b) Kernel Selection: In LibSVM, there are four kernels [linear, sigmoid, gaussian, radial basis function (RBF)]. Individually all kernels were tried to determine best kernel in terms of accuracy. As we observed the best efficiency in RBF, so it was used for classification in the current study.
c) Determination of optimal parameters [cost factor, (C) and kernel parameter (γ )]: Grid search was used to determine optimal value of C and γ , which was found to be 512 and 0.0078125 respectively. Finally the classification model was generated using the best parameters C and γ . The generated model was then tested with test dataset to examine the accuracy of model.
Classification by Artificial Neural Network
MATLAB nntool box was used for implementation of ANN. Classification was carried out using feed-forward back propagation. Mean square error and tan sigmoid was used as performance and transfer function respectively. Several neural network architectures were constructed using different combinations of hidden layers and number of neurons in the hidden layers. Among all the generated networks, one having the best efficiency was chosen as final network. It consists of an input layer, one hidden layer having 10 neurons and an output layer. The weights and bias values were fixed and the network was then tested using a test set of 127 drugs. Confusion matrix was constructed to calculate accuracy of network.
Classification by Bayesian classifier
WEKA was used to implement Bayesian classification. The training and test datasets were the same as used in above two classifiers. Both the test set and training set were converted into WEKA format (.arff file) using a small perl script. Bayes network learns using various search algorithms and quality measures. Base class function provided network structure, conditional probability distributions etc and therefore facilitates common to Bayes Network learning algorithm. Genetic algorithm is used as search algorithm during the classification.
RESULTS AND DISCUSSION
The prediction accuracy of SVM classifier for the test set came out to be 96.85%. Classifier efficiency was determined by calculating number of true positives (TP), number of true negatives (TN), number of false positives (FP) and number of false neg- atives (FN) and these values were found to be 87, 36, 1, and 4 respectively. Using these variables, Sensitivity came out to be 95.6% and 0.79% false positive proportion. Specificity was found to be 97.30% with 3.15% false negative proportion. Youden's Index was calculated as 0.929. Area under ROC was found to be 0.965. From confusion matrix of ANN Number of TP, TN, FP and FN were calculates as 87, 34, 3, 4 respectively. Sensitivity and Specificity of the network was found to be 95.60% and 91.89%. Overall accuracy of network is 94.53. Youden's Index was calculated as 0.87. Area under ROC curve was 0.958.
The accuracy of prediction for Bayesian classifier was found 92.19 for test set. Total correctly classified instances were found to be 118 while incorrectly classified instances were 10. The number of TP, TN, FP and FN were found to be 84, 34, 3 and 7 respectively. The confusion matrix for the prediction was generated. F-test result was 0.923. Area under ROC curve was found to be 0.967, whereas Youden's index was calculated as 0.84. Quite a few researchers have been tried to generate absorption models using different machine learning approaches and reported good results [6, 24] . This is the first time we are presenting a comparative study between three potential machine learning approaches viz. SVM, ANN and Bayesian for the same dataset. The basic idea behind generating the three models is to compare these models and to get some idea about the most efficient machine learning approach for considered oral bioavailability dataset.
The performance of developed classifiers using SVM, ANN and Bayesian classifier were compared to determine most efficient classifier among three for prediction of oral bioavailabil- ity of drugs (Fig. 3) . Precision of SVM was found to be 4.33% and 6.67% greater than ANN and Bayesian classifier respectively. Moreover, accuracy of SVM for this dataset was found to be 2.32% and 4.66% more than ANN and Bayesian classifier respectively. Although sensitivity of ANN and SVM is same for this dataset, but RBF kernels based SVM classifier appears to be the best in terms of accuracy and precision.
CONCLUSION
The study suggests that machine learning approaches such as SVM, ANN and Bayesian classifier are efficient in binary classification based on oral bioavailability of drugs using physicochemical properties. Comparative studies of all three classifiers suggest that overall efficiency of SVM for considered dataset is better followed by ANN and Bayesian classifiers.
